Back to Top Skip to main content

Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency, U.S. Armed Forces, May 2004–September 2018

Staff Sgt. Cory Gage, 23d Medical Support Squadron medical laboratory technician, places a blood specimen in an automated hematology analyzer, Aug. 29, 2017, at Moody Air Force Base, Ga. Moody’s lab technicians process blood to check for a variety of cell abnormalities from infections to cancer. (U.S. Air Force photo by Airman 1st Class Erick Requadt) Staff Sgt. Cory Gage, 23d Medical Support Squadron medical laboratory technician, places a blood specimen in an automated hematology analyzer, Aug. 29, 2017, at Moody Air Force Base, Ga. Moody’s lab technicians process blood to check for a variety of cell abnormalities from infections to cancer. (U.S. Air Force photo by Airman 1st Class Erick Requadt)

Recommended Content:

Medical Surveillance Monthly Report

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited genetic disorder most commonly associated with hemolytic anemia. Among those with G6PD deficiency, hemolytic anemia may be triggered by bacterial or viral infections and by certain foods and drugs, including the 8-aminoquinoline (8-AQ) class of antimalarials. Because 8-AQ drugs remain the only drugs approved by the U.S. Food and Drug Administration for malaria relapse prevention, the Department of Defense (DoD) requires testing of all service members’ G6PD status. To estimate prevalence of G6PD deficiency among DoD service members, Composite Health Care System-generated, Health Level 7-formatted laboratory records for all service members (n=2,311,223) dated between May 2004 and September 2018 were queried for G6PD testing. Corresponding demographic data were obtained from the Defense Enrollment Eligibility Reporting System. Overall prevalence of G6PD deficiency among this cohort was low, at 2.2%. Demographic trends mirrored U.S. statistics; the cohort prevalence among males (2.3%) was higher than among females (1.5%), and the prevalence among non-Hispanic blacks (9.5%) was higher than among those in any other race/ethnicity group.

WHAT ARE THE NEW FINDINGS?    

Test results for 2,311,223 active duty service members over a 14-year period confirmed previous service-specific surveillance reports about the prevalence of G6PD deficiency. The deficiency was found in 2.2% of all service members, and the prevalence ranged from 11.2% among non-Hispanic black males to 0.3% among non-Hispanic white females. To the authors’ knowledge, this is the first DoD report widely addressing the prevalence of G6PD deficiency among active duty service members.

WHAT IS THE IMPACT ON READINESS AND FORCE HEALTH PROTECTION?

Service members who travel or deploy to malaria-endemic regions are at risk of malaria infection. Because of the risk of hemolytic anemia from use of the 8-AQ class of antimalarial drugs (e.g., primaquine, tafenoquine), military leaders should be aware of G6PD deficiency diagnoses among service members under their purview and should continue adherence to current DoD G6PD screening policies.

BACKGROUND

Glucose-6-phosphate dehydrogenase (G6PD) is an essential enzyme for the pentose phosphate pathway in the erythrocyte because it converts glucose-6-phosphate to 6-phosphoglucono-d-lactone. G6PD also converts nicotinamide adenine dinucleotide phosphate (NADP) to the reduced form of NADP (NADPH), a critical redox-active cofactor that mitigates oxidative damage to the erythrocytes.G6PD deficiency is a genetic condition arising from mutations on the Gd gene on the X chromosome that encodes G6PD enzyme. As an X-linked recessive genetic disorder, G6PD deficiency has a higher prevalence in males than females.1 Reduced G6PD activity in G6PD deficient individuals can cause hemolysis with different manifestations (e.g., kernicterus in infants and hemolytic crises) from exposures to oxidative stressors including certain medications, fava beans, and infections.1,2 For example, members of the 8-aminoquinoline (8-AQ) class of antimalarial drugs can cause hemolysis in the G6PD deficient population. 

8-AQ class antimalarial drugs (primaquine and the newly Food and Drug Administration (FDA)-approved tafenoquine for weekly chemoprophylaxis and single-dose radical cure) are important because they target hypnozoites—a dormant form of the malaria parasite common in Plasmodium vivax and P. ovale infections that can emerge from the liver and cause relapse days to years after treatment has cleared the malaria parasites from the circulating red blood cells. Although these infections are less often fatal than P. falciparum infections, they still can cause significant morbidity because of relapse from the dormant form of the parasites. Because the 8-AQ class drugs are the only FDA-approved drugs for malaria relapse prevention, the Department of Defense (DoD) mandated G6PD testing of service members at the time of military accession as early as 1981 (Instruction 6465.13,4 updated with DoD Instruction 6465.015 in 2015 and 6025.146 in 2018), and the Army implemented additional G6PD screening of soldiers deploying to malaria endemic regions as early as 2004.7 However, given that this drug class may trigger hemolytic anemia among those who are G6PD deficient, it is important to adhere to DoD G6PD screening instructions and provide results to command leaders and tested individuals for situational awareness and force protection.

Thus, the objectives of this surveillance report are to describe the prevalence of G6PD deficiency among active duty DoD service members who were screened during 2004–2018 and remind the DoD medical community to consider the risk of hemolytic anemia when prescribing the use of the 8-AQ class of antimalarial drugs.

METHODS

This cross-sectional study used Composite Health Care System-generated, Health Level 7-formatted chemistry laboratory records from 01 May 2004 through 30 September 2018 and queried for G6PD laboratory test results among all active duty, recruit, and active reserve DoD service members tested at fixed military treatment facilities (MTFs). Generally, G6PD testing occurs during accession (recruit training), which is reflected in over 90% of these records.

Key terms used to identify G6PD assays were “G6” or “glucose 6” in the test ordered or test name fields. G6PD tests are often run in panels with other genetic and hemoglobin tests. Records were excluded from the analysis if the test name field contained text indicating other genetic testing (e.g., “sickle cell anemia”), “red blood count,” “hemoglobin testing,” “miscellaneous,” or if the test type could not be determined.

G6PD laboratory test result fields were alpha character–based or numeric. Character-based records with a test result of “Not Deficient,” “High,” or “Normal” were classified as “Not Deficient.” Records with a test result of “Deficient” or “Low” were classified as “Deficient.” Because of laboratory testing variations between MTFs, numeric test results were classified based upon the reference ranges indicated in the record. If a record had no reference range but units of measure were noted, the reference range was inferred based on other tests with the same unit of measure. In an effort to provide an accurate denominator, if the test result was numeric and the units of measure and the reference ranges could not be extrapolated from the data, the record result was classified as “Unknown.” To avoid misclassification of results, if the test result field referred to the free-text result notes field, the record was classified as “Unknown.”

If a service member had more than 1 record and the test results differed, the records were prioritized as follows: a “Deficient” record was retained over a “Not Deficient” or “Unknown” record, and a “Not Deficient” record was retained over an “Unknown” record. Only 1 record per service member was retained for analysis.

Final records were matched to the most recent Defense Enrollment Eligibility Reporting System (DEERS) record for each service member to obtain race/ethnicity and service affiliation. Records were not included in the final dataset if there were no matching DEERS records (n=29,642). Demographic frequencies and distributions for the final cohort were calculated using SAS software, version 9.4 (SAS Institute, Cary, NC).

RESULTS

Overall results are presented in Table 1. G6PD laboratory test results for 2,311,223 service members were evaluated. Examination of laboratory records indicated that the vast majority (97.7%) of service members tested were not G6PD deficient. Only 0.13% of all records could not be classified. The majority of service members represented in this analysis (89.5%) had 1 record for G6PD testing, 8.7% had 2 records, and the remaining 1.8% had 3 or more records (data not shown). Of those with more than 1 record where the classification changed, the following changes were observed: “Not Deficient” to “Deficient” (4.6%), “Unknown” to “Deficient” (3.7%), and “Unknown” to “Not Deficient” (91.7%) (data not shown).

Of the 2,311,223 service members identified in the laboratory records as having been tested, 83.3% were male and 16.7% were female. Sex was not indicated in 3,070 records (0.13%). Males were more likely to be classified as G6PD deficient (2.3%) than females (1.5%).

Race/ethnicity was classified as “other/unknown” in 3.0% of all records (Table 1). Non-Hispanic blacks were most likely to be classified as G6PD deficient (9.5%), followed by Asians/Pacific Islanders (2.9%) and Hispanics (1.5%). Non-Hispanic whites were the least likely to be classified as G6PD deficient (0.4%).

The G6PD classifications stratified by race/ethnicity and sex are shown in Table 2. Among males, non-Hispanic black service members were the most likely to be classified as G6PD deficient (11.2%), followed by Asian/Pacific Islander and Hispanic service members (3.3% and 1.7%, respectively). Non-Hispanic black males were more than twice as likely as non-Hispanic black females (4.7%) to be classified as G6PD deficient. Non-Hispanic black females had the highest proportion of G6PD deficiency of all female race/ethnicity groups. Although the non-Hispanic white race/ethnicity group represented the largest proportion of service members tested (59.8%), males and females in this race/ethnicity group were least likely to be G6PD deficient (0.4% and 0.3%, respectively).

Table 3 illustrates the G6PD results by service. The proportions of service members who tested positive for G6PD deficiency were broadly similar among the services. The Army had the highest percentage of service members with G6PD deficiency (2.7%), followed by the Air Force (2.3%) and Navy (2.2%). The Coast Guard (1.2%) and the Marine Corps (1.1%) had the lowest rates of service members with G6PD deficiency.

EDITORIAL COMMENT

The current study found an overall G6PD deficiency prevalence rate of 2.2% (n=49,897) among the 2,311,223 active and reserve component service members with laboratory results. To the authors’ knowledge, this is the largest study of G6PD deficiency screening among DoD service members. The results of the current analysis are consistent with other studies that have found that non-Hispanic black males are more likely to be G6PD deficient than any other race/ethnicity group.7–10

Before adoption of the newly FDA-approved tafenoquine as the primary force health protection measure for DoD service members against malaria infection, it is critical to understand the indications for prevention and treatment as well as the limitations.11 Regardless of an improved drug performance, including a radical curative efficacy, longer drug half-life, and once-weekly dosing regimen, tafenoquine still retains the risk of inducing hemolytic anemia in G6PD deficient individuals.

The results of this study must be interpreted within the context of several limitations. Laboratory records queried for this analysis were derived from fixed MTFs and do not include records from in-theater, shipboard, battalion aid station, or Purchased CareThe TRICARE Health Program is often referred to as purchased care. It is the services we “purchase” through the managed care support contracts.purchased care providers, although inclusion of these records, were they available, would not be expected to alter the findings presented herein. Genetic testing is generally performed during the accession phase of military service, so very few tests would need to be performed at austere or remote locations. Although validation steps were taken to avoid misclassification, it is possible that some results were misclassified. Because less than 1.0% of all records were classified as “Unknown,” it is unlikely that these results would change the overall prevalence rates. Final laboratory records were matched to the most recent DEERS record for each service member; a service member may have changed service affiliation after the laboratory testing, but this practice is uncommon. Additionally, laboratory data were derived from DoD service members and may not be generalizable to a larger U.S. civilian population.

Given the findings of the current analysis, DoD healthcare providers, Combatant Commanders, and their command surgeons in areas of responsibility that include malaria-endemic regions should remain aware of the risks of 8-AQ hemolytic anemia in G6PD deficient service members. In addition, targeted health education and risk management instruction should be provided to G6PD deficient service members in order to mitigate adverse health outcomes. Furthermore, continued implementation of the DoD’s G6PD screening instruction is required to mitigate G6PD deficiency-associated adverse events.

 

Author affiliations: Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD (MAJ Jangwoo Lee); Defense Health Agency, Combat Support, Healthcare Operations, Public Health Division, Armed Forces Health Surveillance Branch, Navy Satellite (Beth T. Poitras)

Acknowledgments: The authors thank LTC Chad C. Black, LTC Mara Kreishman-Deitrick, COL James E. Moon, COL Viseth Ngauy, MAJ Brandon S. Pybus, and Angela D. Schlein for their support of this analysis and report.

Disclaimer: The views expressed in this report are those of the authors and do not necessarily reflect the official policy or position of the Armed Forces Health Surveillance Branch, the Defense Health Agency, the Department of the Army, the Department of the Navy, the Department of Defense, or the U.S. Government. Analytic support was provided by the Armed Forces Health Surveillance Branch of the Public Health Division at the Defense Health Agency. Authors are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C., §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C., §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.


REFERENCES

1. Richardson SR, O'Malley GF. (2019). Glucose 6 phosphate dehydrogenase (G6PD) deficiency. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK470315/. Accessed 23 January 2019.

2. Luzzatto L, Arese P. Favism and glucose-6-phosphate dehydrogenase deficiency. N Eng J Med. 2018;378(1):60–71.

3. Department of Defense Instruction 6465.1. Hemoglobin S and erythrocyte glucose-6-phosphate dehydrogenase deficiency test program. 29 July 1981.

4. Webber BJ, Witkop CT. Screening for sickle-cell trait at accession to the United States military. Mil Med. 2014;179(11):1184–1189.

5. Department of Defense Instruction 6465.01. Erythrocyte glucose-6-phosphate dehydrogenase deficiency (G6PD) and sickle cell trait screening programs. 17 July 2015.

6. Department of Defense Instruction 6025.14. Active duty service members (ADSM) erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency and sickle cell trait (SCT) screening. 6 December 2018.

7. Chinevere TD, Murray CK, Grant E Jr, Johnson GA, Duelm F, Hospenthal DR. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med. 2006;171(9):905–907.

8. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Eng J Med. 1979;300(18):1001–5.

9. Tarlov AR, Brewer GJ, Carson PE, Alving AS. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med. 1962;109:209–234.

10. Uddin DE, Dickson LG, Brodine CE. Glucose-6-phosphate dehydrogenase deficiency in military recruits. JAMA. 1974;227(12):1408–1409.

11. Fukuda M, Wojnarski M, Martin N, Zottig V, Waters NC. Editorial: Malaria in the Korean Peninsula: risk factors, latent infections, and the possible role of tafenoquine, a new antimalarial weapon. MSMR. 2018;25(11):2–3.

Results of G6PD deficiency laboratory testing among active duty DoD service members, 2004–2018

Classification of G6PD laboratory records among active duty DoD service members, by race/ethnicity and sex, 2004–2018

Classification of G6PD laboratory records among active duty DoD service members, by service, 2004–2018

You also may be interested in...

Surveillance Snapshot: Illness and Injury Burdens, Recruit Trainees, Active Component, U.S. Armed Forces, 2018

Article
5/1/2019
U.S. Navy sailors graduate from boot camp at Recruit Training Command (RTC) in 2018. (Photo courtesy of U.S. Navy)

Recommended Content:

Medical Surveillance Monthly Report

Medical evacuations out of the U.S. Central Command, active and reserve components, U.S. Armed Forces, 2018

Article
5/1/2019
Airmen from the 19th Medical Group litter-carry a simulated patient onto a C-130J during an aeromedical evacuation training mission at Little Rock Air Force Base in 2019. (Photo Courtesy of U.S. Air Force)

The number of medical evacuations for battle injuries has decreased considerably since 2014. Most medical evacuations in 2018 were attributed to mental health disorders, followed by non-battle injury/poisoning; signs, symptoms, and ill-defined conditions; musculoskeletal disorders; and digestive system disorders.

Recommended Content:

Medical Surveillance Monthly Report

Absolute and relative morbidity burdens attributable to various illnesses and injuries, non-service member beneficiaries of the Military Health System, 2018

Article
5/1/2019
A senior airman of 366th Medical Support Squadron pediatric clinic checks vitals of the child of its service member at Mountain Home Air Force Base in Idaho. (Photo courtesy of U.S. Air Force)

In 2018, mental health disorders accounted for the largest proportions of the morbidity and healthcare burdens that affected the pediatric and younger adult beneficiary age groups. Among adults aged 45–64 years, musculoskeletal diseases accounted for the most morbidity and healthcare burdens, and among adults aged 65 years or older, cardiovascular diseases accounted for the most.

Recommended Content:

Medical Surveillance Monthly Report

Morbidity burdens attributable to various illnesses and injuries, deployed active and reserve component service members, U.S. Armed Forces, 2018

Article
5/1/2019
A U.S. naval officer listens through his stethoscope to hear his patient’s lungs at Camp Schwab in Okinawa, Japan in 2018. (Photo courtesy of U.S. Marine Corps) photo by Lance Cpl. Cameron Parks)

Among service members deployed during 2018, injury/poisoning, musculoskeletal diseases, and signs/symptoms accounted for more than half of the total healthcare burden while deployed. Compared to the distribution of major burden of disease categories documented in garrison, a relatively greater proportion of in-theater medical encounters due to respiratory infections, skin diseases, infectious/parasitic diseases, and digestive diseases was documented.

Recommended Content:

Medical Surveillance Monthly Report

Absolute and relative morbidity burdens attributable to various illnesses and injuries, active component, U.S. Armed Forces, 2018

Article
5/1/2019
A U.S. naval officer listens through his stethoscope to hear his patient’s lungs at Camp Schwab in Okinawa, Japan in 2018. (Photo courtesy of U.S. Marine Corps) photo by Lance Cpl. Cameron Parks)

In 2018, mental health disorders accounted for the largest proportions of the morbidity and healthcare burdens that affected the pediatric and younger adult beneficiary age groups. Among adults aged 45–64 years, musculoskeletal diseases accounted for the most morbidity and healthcare burdens, and among adults aged 65 years or older, cardiovascular diseases accounted for the most.

Recommended Content:

Medical Surveillance Monthly Report

Heat Illness

Infographic
4/1/2019
Heat Illness

This report summarizes reportable medical events of heat illness as well as heat illness-related hospitalizations and ambulatory visits among active component service members during 2018 and compares them to the previous 4 years. Episodes of heat stroke and heat exhaustion are summarized separately.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Rhabdomyolysis

Infographic
4/1/2019
Exertional Rhabdomyolysis

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Hyponatremia

Infographic
4/1/2019
Exertional Hyponatremia

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Lyme Disease

Infographic
4/1/2019
Lyme Disease

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Update: Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2014–2018

Article
4/1/2019
U.S. Marines sprint uphill during a field training exercise at Marine Corps Air Station Miramar, California. to maintain contact with an aviation combat element, teaching and sustaining their proficiency in setting up and maintaining communication equipment.  (Photo Courtesy: U.S. Marine Corps)

Among active component service members in 2018, there were 545 incident diagnoses of rhabdomyolysis likely due to exertional rhabdomyolysis, for an unadjusted incidence rate of 42.0 cases per 100,000 person-years. Subgroup-specific rates in 2018 were highest among males, those less than 20 years old, Asian/Pacific Islander service members, Marine Corps and Army members, and those in combat-specific or “other/unknown” occupations. During 2014–2018, crude rates of exertional rhabdomyolysis increased steadily from 2014 through 2016 after which rates declined slightly in 2017 before increasing again in 2018. Compared to service members in other race/ethnicity groups, the overall rate of exertional rhabdomyolysis was highest among non-Hispanic blacks in every year except 2018. Overall and annual rates were highest among Marine Corps members, intermediate among those in the Army, and lowest among those in the Air Force and Navy. Most cases of exertional rhabdomyolysis were diagnosed at installations that support basic combat/recruit training or major ground combat units of the Army or the Marine Corps. Medical care providers should consider exertional rhabdomyolysis in the differential diagnosis when service members (particularly recruits) present with muscular pain or swelling, limited range of motion, or the excretion of dark urine (possibly due to myoglobinuria) after strenuous physical activity, particularly in hot, humid weather.

Recommended Content:

Medical Surveillance Monthly Report

Update: Heat Illness, Active Component, U.S. Armed Forces, 2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

In 2018, there were 578 incident diagnoses of heat stroke and 2,214 incident diagnoses of heat exhaustion among active component service members. The overall crude incidence rates of heat stroke and heat exhaustion diagnoses were 0.45 cases and 1.71 cases per 1,000 person-years, respectively. In 2018, subgroup-specific rates of incident heat stroke diagnoses were highest among males and service members less than 20 years old, Asian/Pacific Islanders, Marine Corps and Army members, recruit trainees, and those in combat-specific occupations. Subgroup-specific incidence rates of heat exhaustion diagnoses in 2018 were notably higher among service members less than 20 years old, Asian/Pacific Islanders, Army and Marine Corps members, recruit trainees, and service members in combat-specific occupations. During 2014–2018, a total of 325 heat illnesses were documented among service members in Iraq and Afghanistan; 8.6% (n=28) were diagnosed as heat stroke. Commanders, small unit leaders, training cadre, and supporting medical personnel must ensure that the military members whom they supervise and support are informed about the risks, preventive countermeasures, early signs and symptoms, and first-responder actions related to heat illnesses.

Recommended Content:

Medical Surveillance Monthly Report

Modeling Lyme Disease Host Animal Habitat Suitability, West Point, New York

Article
4/1/2019
A deer basks in the morning sun at Joint Base San Antonio-Fort Sam Houston, Texas.  (Photo Courtesy: U.S. Air Force)

As the most frequently reported vector-borne disease among active component U.S. service members, with an incidence rate of 16 cases per 100,000 person-years in 2011, Lyme disease poses both a challenge to healthcare providers in the Military Health System and a threat to military readiness. Spread through the bite of an infected blacklegged tick, infection with the bacterial cause of Lyme disease can have lasting effects that may lead to medical discharge from the military. The U.S. Military Academy at West Point is situated in a highly endemic area in New York State. To identify probable areas where West Point cadets as well as active duty service members stationed at West Point and their families might contract Lyme disease, this study used Geographic Information System mapping methods and remote sensing data to replicate an established spatial model to identify the likely habitat of a key host animal—the white-tailed deer.

Recommended Content:

Medical Surveillance Monthly Report

Incidence, Timing, and Seasonal Patterns of Heat Illnesses During U.S. Army Basic Combat Training, 2014–2018

Article
4/1/2019
U.S. Marines participate in morning physical training during a field exercise at Marine Corps Base Camp Pendleton, California. (Photo Courtesy: U.S. Marine Corps)

Risk factors for heat illnesses (HIs) among new soldiers include exercise intensity, environmental conditions at the time of exercise, a high body mass index, and conducting initial entry training during hot and humid weather when recruits are not yet acclimated to physical exertion in heat. This study used data from the Defense Health Agency’s–Weather-Related Injury Repository to calculate rates and to describe the incidence, timing, and geographic distribution of HIs among soldiers during U.S. Army basic combat training (BCT). From 2014 through 2018, HI events occurred in 1,210 trainees during BCT, resulting in an overall rate of 3.6 per 10,000 BCT person-weeks (p-wks) (95% CI: 3.4–3.8). HI rates (cases per 10,000 BCT p-wks) varied among the 4 Army BCT sites: Fort Benning, GA (6.8); Fort Jackson, SC (4.4); Fort Sill, OK (1.8); and Fort Leonard Wood, MO (1.7). Although the highest rates ofHIs occurred at Fort Benning, recruits in all geographic areas were at risk. The highest rates of HI occurred during the peak training months of June through September, and over half of all HI cases affected soldiers during the first 3 weeks of BCT. Prevention of HI among BCT soldiers requires relevant training of both recruits and cadre as well as the implementation of effective preventive measures.

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2003–2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

From 2003 through 2018, there were 1,579 incident diagnoses of exertional hyponatremia among active component service members, for a crude overall incidence rate of 7.2 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, females, those less than 20 years old, and recruit trainees had higher overall incidence rates of exertional hyponatremia diagnoses. The overall incidence rate during the 16-year period was highest in the Marine Corps, intermediate in the Army and Air Force, and lowest in the Navy. Overall rates during the surveillance period were highest among Asian/Pacific Islander and non-Hispanic white service members and lowest among non-Hispanic black service members. Between 2003 and 2018, crude annual incidence rates of exertional hyponatremia peaked in 2010 (12.7 per 100,000 p-yrs) and then decreased to 5.3 cases per 100,000 p-yrs in 2013 before increasing in 2014 and 2015. The crude annual rate in 2018 (6.3 per 100,000 p-yrs) represented a decrease of 26.5% from 2015. Service members and their supervisors must be knowledgeable of the dangers of excessive water consumption and the prescribed limits for water intake during prolonged physical activity (e.g., field training exercises, personal fitness training, and recreational activities) in hot, humid weather.

Recommended Content:

Medical Surveillance Monthly Report

Sexually Transmitted Infections

Infographic
3/20/2019
Sexually Transmitted Infections

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health
<< < ... 6 7 8 9 10  ... > >> 
Showing results 91 - 105 Page 7 of 12

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.